Jean Jacques Bienaime - 20 May 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 May 2024, 16:09:39 UTC
Prior SEC filing
13 May 2024
Next SEC filing
22 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tae Sang Yoo, Attorney-in-Fact

Key filing fact

Jean Jacques Bienaime filed Form 4 for BIOMARIN PHARMACEUTICAL INC (BMRN) on 21 May 2024.

Key facts

  • This page summarizes Jean Jacques Bienaime's Form 4 filing for BIOMARIN PHARMACEUTICAL INC (BMRN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 May 2024, 16:09.

Change

  • Previous filing in this sequence was filed on 13 May 2024.
  • Current net transaction value: -$92,614.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMRN transaction

Common Stock

Tax liability

Transaction value
$92,614
Shares
-1,202
Change %
-0.25%
Price
$77.05
Shares after
473,792
Date
20 May 2024
Ownership
Direct
BMRN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
247,333
Date
20 May 2024
Ownership
Shares held by Jean-Jacques Bienaime Family Trust
BMRN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
100
Date
20 May 2024
Ownership
Shares held as UTMA custodian for child 1
BMRN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
100
Date
20 May 2024
Ownership
Shares held as UTMA custodian for child 2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jean Jacques Bienaime is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .